SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Abro, E.
Right arrow Articles by Delbridge, L. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Abro, E.
Right arrow Articles by Delbridge, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction

Emad Abro

Department of Physiology, University of Melbourne, Parkville, Victoria, 3010, Australia

Cory D Griffiths

Department of Physiology, University of Melbourne, Parkville, Victoria, 3010, Australia

Trefor O Morgan

Department of Physiology, University of Melbourne, Parkville, Victoria, 3010, Australia

Lea MD Delbridge

Department of Physiology, University of Melbourne, Parkville, Victoria, 3010, Australia, l.delbridge{at}physiology.unimelb.edu.au

Altered operation of the renin-angiotensin-aldosterone system (RAAS) and dietary sodium intake have been identified as independent risk factors for cardiac hypertrophy. The way in which sodium intake and the operation of the renin-angiotensin-aldosterone system interact in the pathogenesis of cardiac hypertrophy is poorly understood. The aims of this study were to investigate the cardiac effects of the renin-angiotensin system (RAS) blockade in the spontaneously hypertensive rat (SHR), using co-treatment with an angiotensin II receptor blocker (ARB) and an angiotensin-converting enzyme (ACE) inhibitor with different sodium intakes. Our experiments with SHR show that, at high levels of sodium intake (4.0%), aggressive RAS blockade treatment with candesartan (3 mg/kg) and perindopril (6 mg/kg) does not result in regression of cardiac hypertrophy. In contrast, RAS blockade coupled with reduced sodium diet (0.2%) significantly regresses cardiac hypertrophy, impairs animal growth and is associated with elevated plasma renin and dramatically suppressed plasma angiotensinogen levels. Histological analyses indicate that the differential effect of reduced sodium on heart growth during RAS blockade is not associated with any change in myocardial interstitial collagen, but reflects modification of cellular geometry. Dimensional measurements of enzymatically-isolated ventricular myocytes show that, in the RAS blocked, reduced sodium group, myocyte length and width were decreased by about 16—19% compared with myocytes from the high sodium treatment group. Our findings highlight the importance of `titrating' sodium intake with combined RAS blockade in the clinical setting to optimise therapeutic benefit.

Key Words: angiotensin receptor blocker • angiotensin-converting enzyme inhibitor • cardiac hypertrophy • myocardial fibrosis • cardiomyocyte

References

  • Levy D., Garrison RJ, Savage DD, Kannel WB, Castelli WP Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Eng Med 1990; 322:1561-6.
  • Morgan TO, Griffiths CD, Delbridge LMD. Wall stress, angiotensin II and left ventricular hypertrophy. In: M Epstein and H Brunner Eds. Angiotensin-II Receptor antagonists. Philadelphia: Hanley &Belfus, 2001; Chapter 15:223-34.
  • Hunter J., Chien K. Signalling pathways for cardiac hypertrophy and failure. N Eng J Med 1999; 341:1276-83.[Free Full Text]
  • Farhadian F., Contard F., Corbier A., Barriex A., Rappaport L., Samuel JL Fibronectin expression during physiological and pathological cardiac growth. Journal of Molecular & Cellular Cardiology 1995; 27: 981-90.[CrossRef]
  • Dahlof B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients.A metaanalysis of 109 treatment studies.Am JHypertens 1992; 5:95-110.
  • Danser AHJ, Schalekamp ADH, Bax WA, et al. Angiotensin-converting enzyme in the human heart. Circulation 1995; 92:1387-8.[Abstract/Free Full Text]
  • Mazzolai L., Pedrazinni T., Nicoud F., Gabbiani G., Brunner H., Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension 2000; 35:985-91.[Abstract/Free Full Text]
  • Schmeider RE, Messerli FH, Garavaglia GE, Nunez BD Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-6.[Abstract/Free Full Text]
  • du Cailar G., Ribstein J., Grolleau R., Mimran A. Influence of sodium intake on left ventricular structure in untreated essential hypertensives.JHypertens 1989; 7:S258-9.[Web of Science]
  • Wilson RB, Smith DM, Newberne PM Excess sodium chloride intake in neonatal rats. Arch Pathol 1973; 96:372-6.[Web of Science][Medline] [Order article via Infotrieve]
  • McGormick CP, Rauch AL, Buckalew Jr WM Differential effect of dietary salt on renal growth in Dahl salt-sensitive and salt-resistant rats. Hypertension 1989; 13:122-7.[Abstract/Free Full Text]
  • Azizi M., Guyene TT, Chatellier G., Wargon M., Menard J. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Hypertension 1997; 29:634-40.[Abstract/Free Full Text]
  • Sever P. Intra-individual responses to blockade of the renin-angiotensin system by an ACE inhibitor (lisinopril) and an angiotensin receptor antagonist (candesartan). JRAAS 2000; 1:104.
  • Menard J., Campbell DJ, Azizi M., Gonzales MF Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997; 96:3072-8.[Abstract/Free Full Text]
  • Morsing P., Adler G., Brandt-Eliasson U. et al. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension 1999; 33:1406-13.[Abstract/Free Full Text]
  • Di Nicolantonio R., Silvapulle MJ, Spargo S., Morgan TO High salt diet decreases longevity in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1988; 15:357-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Campbell DJ, Rong P., Kladis A., Rees B., Ganten D., Skinner SL Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 1995; 25:1014-20.[Abstract/Free Full Text]
  • Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 1998; 54:343-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Delbridge LMD, Connell PJ, Harris PJ, Morgan TO Acute effects of low ethanol concentrations on isolated rat cardiac myocyte contractility. Clin Science 2000; 4:401-7.
  • Mervaala E., Laakso J., Vapaatalo H., Karppanen H. Effects of enalapril and hydrochlorothiazide on salt-induced cardiac and renal hypertrophy in normotensive rats. Naunyn-Schmiedeberg's Archiv Pharmacol 1994; 350:416-25.
  • Yuan B., Leenen FHH. Dietary sodium and left ventricular hypertrophy in normotensive rats. Am J Physiol 1991; 261:H1397-H1401.[Web of Science][Medline] [Order article via Infotrieve]
  • Mervaala E., Malmberg L., Teravainen T., Laakso J., Vapaatalo H., Karppanen H. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats. Br J Pharmacol 1998; 123:195-204.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Griffiths CD, Delbridge LMD, Morgan TO High salt intake reverses the cardiovascular effects of high dose perindopril and losartan treatment in normotensive rats. Proc Aust Physiol Pharmacol Soc 1999; 30(2):76P.
  • Barret G., Morgan TO, Smith M.,Alcorn D.,Aldred P. Effect of converting enzyme inhibition on renin synthesis and secretion in mice. Hypertension 1989;14:385-95.[Abstract/Free Full Text]
  • Delbridge LM, Morgan TO, Harris PJ Effects of endothelin-1 on the contractility of cardiomyocytes from the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1995; 22:755-62.[Web of Science][Medline] [Order article via Infotrieve]
  • Song K.,Allen AM, Paxinos G., Mendelsohn FA Mapping of angiotensin II receptor subtype heterogeniety in rat brain. J Comp Neurol 1992;316:467-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Blair-West JR, Carey KD, Denton DA, Weisinger RS, Shade RE Evidence that brain angiotensin II is involved in both thirst and sodium appetite in baboons. Am J Physiol 1998; 275:R1639-46.[Web of Science][Medline] [Order article via Infotrieve]
  • Brown L., Duce B., Miric G., Sernia C. Reversal of cardiac fibrosis in deoxycortisone acetate-salt rats by inhibition of the renin-angiotensin system. J Am Soc Nephrol 1999;10:S143-S148.[Web of Science][Medline] [Order article via Infotrieve]
  • KagoshimaT., Masuda J., Sutani T. et al. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats. Blood Pressure (suppl) 1994; 5:89-93.
  • Navis G., de Jong PE, Donker AJM, van der Hem K., de Zeeuw D. Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol 1987; 9:743-8.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl, S148-S153 (2001)
DOI: 10.1177/14703203010020012601


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Abro, E.
Right arrow Articles by Delbridge, L. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Abro, E.
Right arrow Articles by Delbridge, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement